HEMANGEOL
Live / Registered — Registered and renewed (as of 10 Jan 2025)
What this means for you
Registered since 23 Sept 2014. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 23 Sept 2024).
Record
- Serial number
- 86183672
- Registration number
- 4611446
- Mark type
- Stylized text
- Filed
- 04 Feb 2014
- Published for opposition
- 27 May 2014
- Registered
- 23 Sept 2014
- Next maintenance due
- 23 Sept 2024
- Attorney of record
- G. Patrick SAGE
Goods and services
- Class 005 — Pharmaceuticals: Medicines for treating hemangioma
Owner
- PIERRE FABRE DERMATOLOGIE, BOULOGNE, FR
- PIERRE FABRE DERMATOLOGIE, BOULOGNE, FR
- PIERRE FABRE DERMATOLOGIE, BOULOGNE, FR
Prior registrations
Prosecution history
- 10 Jan 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 10 Jan 2025 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 10 Jan 2025 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 10 Jan 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 23 Sept 2024 — TEAS SECTION 8 & 9 RECEIVED
- 23 Sept 2023 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 15 Oct 2020 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 15 Oct 2020 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 15 Oct 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 28 Aug 2020 — TEAS SECTION 8 & 15 RECEIVED
- 23 Sept 2019 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 23 Sept 2014 — REGISTERED-PRINCIPAL REGISTER
- 21 Aug 2014 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 20 Aug 2014 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 18 Aug 2014 — STATEMENT OF USE PROCESSING COMPLETE